You are here: Industry Insights > COVID-19

News List

Will the industry sell COVID-19 meds at the min production costs? expresspharma
April 15, 2020
Will the pharma industry come through? Can the pharma industry resist pressures from investors and shareholders and sacrifice profits this time?
Jenner Institute, MilliporeSigma to Scale Up Covid-19 Vax Production contractpharma
April 15, 2020
Develops a rapid, scalable platform following good manufacturing practices and using disposable technologies.
Lilly to test Olumiant, LY3127804 against COVID-19 pharmatimes
April 14, 2020
Lilly has linked with health officials in the US to assess its rheumatoid arthritis drug Olumiant (baricitinib) in patients hospitalised with COVID-19.
OncoImmune receives FDA approval for COVID-19 clinical trial pharmaceutical-business-review
April 14, 2020
OncoImmune has received a study-may-proceed letter from the FDA for its Phase III clinical trial testing the safety and efficacy of CD24Fc for the treatment of hospitalized COVID-19 patients (SAC-COVID).
Fast tracks testing of COVID-19 therapies worldpharmanews
April 14, 2020
A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched at UPMC to address one of the most important debates during the COVID-19 pandemic.
Mylan Updates COVID-19 Response americanpharmaceuticalreview
April 14, 2020
Mylan Chairman Robert J. Coury and Chief Executive Officer Heather Bresch provided additional detail regarding the company's efforts to meet public health needs amid the evolving COVID-19 pandemic.
Biohaven to Proceed with Intranasal Vazegepant Trial for COVID-19 Lung Inflammation americanpharmaceuticalreview
April 14, 2020
Biohaven Pharmaceutical announced it submitted Pre-IND/IND material to the U.S. Food and Drug Administration (FDA) to initiate a Phase 2 study of vazegepant.
Vir selects Samsung Biologics to produce Covid-19 antibodies pharmaceutical-technology
April 14, 2020
Immunology company Vir Biotechnology has selected South Korea-based Samsung Biologics for large-scale production of antibodies to potentially treat Covid-19.
Immunomic partners EpiVax and PharmaJet on Covid-19 vaccine pharmaceutical-technology
April 14, 2020
Biotechnology firm Immunomic Therapeutics has partnered with EpiVax and PharmaJet to develop a vaccine candidate against Covid-19 infection.
Theravance Responds to COVID-19 Pandemic contractpharma
April 14, 2020
Theravance Biopharma said that it is advancing TD-0903, a lung-selective nebulized Janus kinase inhibitor (JAKi) into clinical development.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page